Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1. (Q52932701)
Jump to navigation
Jump to search
scientific article published in June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1. |
scientific article published in June 2006 |
Statements
Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1. (English)
1 reference
Corinna Leng
1 reference
Margarethe Gries
1 reference
Judy Ziegler
1 reference
Anna Lokshin
1 reference
Paolo Mascagni
1 reference
Suzanne Lentzsch
1 reference
Markus Y Mapara
1 reference
1 June 2006
1 reference
34
1 reference
6
1 reference
776-787
1 reference